Metabolic activity by 18 F –FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
ConclusionMetabolic response by18F –FDG was effective in predicting efficacy and survival at 1 month after nivolumab treatment.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Lung Cancer | Non-Small Cell Lung Cancer | Nuclear Medicine | PET Scan | Study